dextromethorophan; placebo; diphenhydramine/phenylephrine/cocoa — Competitive Intelligence Brief

dextromethorophan; placebo; diphenhydramine/phenylephrine/cocoa (dextromethorophan; placebo; diphenhydramine/phenylephrine/cocoa) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Combination cold and cough remedy. Area: Respiratory / Cold and Cough.

marketed Combination cold and cough remedy Respiratory / Cold and Cough Small molecule

Target snapshot

dextromethorophan; placebo; diphenhydramine/phenylephrine/cocoa (dextromethorophan; placebo; diphenhydramine/phenylephrine/cocoa) — Montefiore Medical Center. This is a combination product containing dextromethorphan (a cough suppressant), diphenhydramine (an antihistamine), phenylephrine (a decongestant), and cocoa, used to manage cold and cough symptoms.

Comparator set (1 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
dextromethorophan; placebo; diphenhydramine/phenylephrine/cocoa TARGET	dextromethorophan; placebo; diphenhydramine/phenylephrine/cocoa	Montefiore Medical Center	marketed	Combination cold and cough remedy
placebo; diphenhydramine/phenylephrine/cocoa; dextromethorphan	placebo; diphenhydramine/phenylephrine/cocoa; dextromethorphan	Montefiore Medical Center	marketed	Combination cold and cough remedy	H1 receptor (diphenhydramine); alpha-1 adrenergic receptor (phenylephrine); sigma-1 receptor and NMDA receptor (dextromethorphan)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Combination cold and cough remedy class)

1. Montefiore Medical Center · 2 drugs in this class